New T1D Equity Framework Partnership with Medtronic Inc.
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
Screening for T1D: Using the New T1Detect Kit
Chatting with Dexcom CEO About the New G7, the Sampling Program, and the Patient Voice
There are approximately 900,000 people across the globe wearing a Dexcom continuous glucose monitor (CGM) today. “Up from 600,000 at…
We Honor These Words
“Life’s most urgent and persistent question is, What are you doing for others?” – Martin Luther King Jr T1D Exchange…
Racial Inequities Among People with Type 1 Diabetes and COVID-19
T1D Exchange is honored to have our recent study results examining racial inequities among people with type 1 diabetes and COVID-19 included in two major publications. Structural and systemic…
2020 Highlights: COVID-19 Guidance, Daily Hurdles of T1D and Mental Health
At T1D Exchange, we strive to post articles that connect the T1D community. Today we’re sharing the three most viewed…
How to Have a Safer Holiday
With COVID-19 numbers rapidly rising across the United States and the holidays quickly approaching, it makes sense that people with diabetes and…
National Diabetes Awareness Month 2020: The Highlights
Even in the midst of a global pandemic, the diabetes community united to celebrate an unforgettable National Diabetes Awareness Month (NDAM) throughout…
Mike Norwood of Wears Woody Shares His Story
Mike Norwood, Founder and Creative Director of Wears Woody shares his story about starting a company while living with type…
